USE OF KETANSERIN TARTRATE FOR THE TREATMENT OF CHAGAS DISEASE AS AN ANTI-TRYPANOSOMA CRUZI AGENT.

摘要

The present invention refers to the use of ketanserin tartrate with excellent selectivity on Trypanosoma cruzi, which comprises ketanserin tartrate, as well as its pharmaceutically acceptable salts and its use in medicaments for treating humans and mammals with Chagas disease or American trypanosomiasis.